MarketInOut Stock Screener Log In | Sign Up

Exagen Inc

NASDAQ • Healthcare • Diagnostics & Research • Quote as of 10/30/2026
Exagen Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization188.47 mln
Float14.59 mln
Earnings Date11/10/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-3.96
Highly reliable

1-Year Forecast

10.57
Attractive

Relative Strength

92 / 100
Top performer

Debt / Equity

2.26
Very high leverage

Pre-Tax Margin

-27%
Deeply loss-making

Business Description

Exagen Inc. is a US-based medical testing company that develops and sells a suite of diagnostic tools under the AVISE brand, helping doctors identify, assess, and track complex autoimmune conditions such as lupus and rheumatoid arthritis. Its tests analyze specific proteins and biomarkers found in patients' blood to support more accurate diagnosis and treatment decisions. Founded in 2002 and based in Vista, California, the company also collaborates with the Allegheny Health Network Research Institute to advance next-generation biomarker research.

Key Fundamentals

EPS-0.81
ROE-114
RPS3.01
ROIC-56.60
ROA-33.24
Interest Cover-2.58
EBITDA, mln-11.32
EV / EBITDA-17.75
EV / EBIT-14.60
Revenue, mln71.12
EV / Revenue2.82

Quote Details

Last 8.59
Change -0.11 (-1.26%)
Open 8.58
Volume 393,690
Turnover 3,381,797
Average Volume 370,787

Financial Ratios

Pre-Tax Profit Margin-27
Leverage Ratio4.25
Current Ratio3.19
Price / Book16.02
Price / Tangible Book16.02
Debt / Equity2.26
Price / Sales2.72

Financial Strength

Altman Z-Score-4.45
Piotroski F-Score 4 / 9
Beneish M-Score-3.96
1-Year Target Price10.57
Short Ratio2.68
Short % of Float3.21

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 18.16% 97 / 100   
1 Month 8.87% 90 / 100   
2 Months 95.23% 99 / 100   
6 Months 181% 99 / 100   
1 Year -27.51% 27 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog